HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 18 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $12,000 | +100.0% | 38,103 | +277.1% | 0.00% | – |
| Q3 2019 | $6,000 | -80.6% | 10,103 | -47.1% | 0.00% | – |
| Q2 2019 | $31,000 | -55.7% | 19,103 | -31.8% | 0.00% | – |
| Q1 2019 | $70,000 | -1.4% | 28,003 | 0.0% | 0.00% | – |
| Q4 2018 | $71,000 | -49.6% | 28,003 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $141,000 | +60.2% | 28,003 | +3.7% | 0.00% | – |
| Q2 2018 | $88,000 | +8.6% | 27,003 | +20.0% | 0.00% | – |
| Q1 2018 | $81,000 | +200.0% | 22,503 | +66.7% | 0.00% | – |
| Q4 2017 | $27,000 | – | 13,503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,689,064 | $5,506,000 | 3.35% |
| PERKINS CAPITAL MANAGEMENT INC | 249,700 | $814,000 | 0.58% |
| Private Wealth Partners, LLC | 900,000 | $2,934,000 | 0.49% |
| Diametric Capital, LP | 60,752 | $198,000 | 0.19% |
| Granahan Investment Management | 915,449 | $2,984,000 | 0.18% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $815,000 | 0.11% |
| Kalos Management, Inc. | 38,000 | $137,000 | 0.06% |
| Spark Investment Management LLC | 203,600 | $663,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 199,500 | $650,000 | 0.03% |
| Crow Point Partners, LLC | 25,860 | $84,000 | 0.02% |